This, despite the fact that there is still no specific drug or treatment to treat or prevent COVID-19, according to the World Health Organization (WHO).
Federal authorities announced the donation of the hydroxychloroquine medication, by the pharmaceutical company Novartis, to treat 20,000 hospitalized patients with COVID-19.
According to the director-general of Europe in the Ministry of Foreign Relations, Bernardo Aguilar, the delivery of the drug was made this May 21 at the National Institute of Medical Sciences and Nutrition Salvador Zubirán.
This, despite the fact that there is still no specific drug or treatment to treat or prevent COVID-19, according to the World Health Organization (WHO). In fact, the WHO specifically notes that “although several drug trials are underway, no hydroxychloroquine or any other drug has yet been shown to cure or prevent COVID-19.”
Meanwhile, Novartis explained that the Mexican authorities will be responsible for distributing the drug to hospitals.
“The objective of the donation is to allow patients in Mexico to access a potential treatment that is being evaluated globally to care for patients in the special circumstances we are facing and which represents hope within the therapeutic arsenal to combat COVID-19 “Said the president of Novartis Mexico, Fernando Cruz.
The Mazatlan Post